Weill Cornell Medical College The Rockefeller University Memorial Sloan-Kettering Cancer Center

Apply Online Application Due: December 1, 2013

TPCB Faculty

Jeremy Rock, PhD

Rockefeller University


PhD, 2012, Massachusetts Institute of Technology

BA, 2004, University of California, Berkeley

Research Topics

  • Bioactive Small Molecules
    • High-throughput screening assays
    • Chemical probe development
  • Chemical Cell Biology
    • Chemical genetics

Therapeutic Areas

  • Microbiology

photoMycobacterium tuberculosis (Mtb) is one of the leading causes of death due to infectious disease and infects one-quarter of the world’s population. New drugs, drug regimens, and innovative approaches to limit drug resistance are desperately needed. To facilitate their development, the Rock Lab seeks to provide a more complete understanding of the interaction between Mtb, the host, and antibiotics. The lab is taking a functional and chemical genomic approach to, among other things, identify and characterize high-value, druggable Mtb targets, characterize small molecule inhibitors with novel mechanisms of action, and define the design rules for synergistic antibiotic regimens capable of shortening the course of treatment and reversing drug resistance.

Read more about Prof. Rock’s research on the Rockefeller University website

Apply Online!